Covington Capital Management’s Idexx Laboratories IDXX Stock Holding History

Covington Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.58M	Buy	4,844 +140	+3%	+$51.4K	0.07%	188
2022 Q2	$1.65M	Sell	4,704 -737	-14%	-$301K	0.07%	191
2022 Q1	$2.98M	Buy	5,441 +357	+7%	+$188K	0.11%	163
2021 Q4	$3.35M	Buy	5,084 +350	+7%	+$220K	0.12%	156
2021 Q3	$2.94M	Buy	4,734 +350	+8%	+$235K	0.11%	160
2021 Q2	$2.77M	Buy	4,384 +347	+9%	+$192K	0.11%	162
2021 Q1	$1.98M	Buy	4,037 +2,593	+180%	+$1.3M	0.08%	175
2020 Q4	$722K	Sell	1,444 -300	-17%	-$134K	0.03%	231
2020 Q3	$686K	Hold	1,744	–	–	0.03%	228
2020 Q2	$576K	Hold	1,744	–	–	0.03%	227
2020 Q1	$422K	Sell	1,744 -20	-1%	-$5.22K	0.03%	238
2019 Q4	$461K	Buy	1,764 +20	+1%	+$5.27K	0.02%	238
2019 Q3	$474K	Hold	1,744	–	–	0.03%	233
2019 Q2	$480K	Buy	+1,744	New	+$430K	0.03%	226

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Covington Capital Management's IDXX Position: Q3 2022 in Review

Covington Capital Management increased its Idexx Laboratories (IDXX) stake by 3% in Q3 2022, buying an estimated $51.4K and bringing the position to 4,844 shares worth $1.58M. The position accounts for 0.07% of the portfolio, ranked #188.

Covington Capital Management first reported a position in IDXX in Q2 2019 and has held it in 14 quarters since. The position peaked at $3.35M in Q4 2021. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Covington Capital Management held 4,844 shares of Idexx Laboratories worth $1.58M as of Q3 2022.
Covington Capital Management bought 140 Idexx Laboratories shares in Q3 2022, an estimated $51.4K.
Idexx Laboratories made up 0.07% of Covington Capital Management's portfolio in Q3 2022, its #188 holding.
Covington Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 14 quarters since.
Covington Capital Management's Idexx Laboratories position peaked at $3.35M in Q4 2021.
925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.